JPRN-UMIN000013088Completed未知
Efficacy and safety of simeprevir with pegylated interferon alfa-2b and ribavirin in kidney transplant patients with chronic hepatitis C - Efficacy and safety of simeprevir with pegylated interferon alfa-2b and ribavirin in kidney transplant patients with chronic hepatitis C
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Osaka University
- Enrollment
- 18
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional,observational
Eligibility Criteria
- Ages
- 20years-old to 70years-old (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1) Co-infection with hepatitis B virus 2) Co-infection with anti-human immunodeficiency virus 3) Other forms of liver disease (alcohol liver disease, autoimmune hepatitis etc.) 4) Decompensated cirrhosis, Liver failure 5) Contraindication to pegylated interferon 6) Contraindication to ribavirin
Investigators
Similar Trials
Not yet recruiting
Not Applicable
Efficacy and safety of simeprevir with pegylated interferon alfa and low dose of ribavirin for patients with chronic hepatitis C genotype 1 and low hemoglobin levelJPRN-UMIN000018476Osaka University Graduate School of Medicine, Department of Gastroenterology and Hepatology55
Not yet recruiting
Not Applicable
Efficacy and safety of simeprevir with pegylated interferon alfa and ribavirin in patients with chronic hepatitis CPatients with chronic hepatitis C virus infectionJPRN-UMIN000012183Osaka University Graduate School of Medicine, Department of Gastroenterology and Hepatology500
Completed
Not Applicable
Efficacy and safety of simeprevir plus pegylated intereferon combination therapy for HCV genotype 1 patients with chronic renal failurechronic infection with hepatitis C virusJPRN-UMIN000012668Osaka University Graduate school of Medicine45
Completed
Not Applicable
Efficacy and safety of simeprevir/pegylated-interferon/ribavirin combination therapy with Vitamin D3 in chronic hepatitis C patients: multi-center, open label, randomized, controlled studyChronic hepatitis CJPRN-UMIN000013017ippon Medical School Chiba Hokusoh Hospital150
Recruiting
Not Applicable
Efficacy and safety of Simeprevir/PEG alpha-IFN-2a/RBV therapy for patients with chronic hepatitis C after resection of hepatocellular carcinomaChronic hepatitis CJPRN-UMIN000012937Kansai Medical University100